Duygudurum Düzenleyiciler, Anksiyolitikler ve Ürogenital Yan Etkileri
Özet
Duygudurum bozuklukları ve anksiyete bozukluklarının tedavisinde kullanılan farmakoterapötik ajanlar, psikiyatrik stabilitenin sağlanmasında vazgeçilmez bir yere sahip olmalarına rağmen, ürogenital sistem ve cinsel işlevler üzerinde hedef dışı etkilere yol açabilmektedir. Lityum tedavisi, böbrek toplayıcı kanallarındaki epitelyal sodyum kanalları (ENaC) aracılığıyla hücre içine girerek hücre içi sinyal iletim yollarını ve Aquaporin-2 (AQP2) su kanallarının translokasyonunu bozmakta; bu durum hastaların en az yarısında idrar konsantrasyon kusuruna ve yaklaşık %10-20'sinde semptomatik nefrojenik diabetes insipidusa (NDI) yol açmaktadır. Aynı zamanda lityum, nitrik oksit (NO) ve testosteron yolaklarını inhibe ederek hastaların yaklaşık üçte birinde cinsel işlev bozukluklarını tetiklemektedir. Valproat, histon deasetilaz inhibisyonu yoluyla over teka hücrelerinde androjen biyosentezini doğrudan uyararak polikistik over sendromu (PKOS) benzeri tablolar oluşturmakta ve üreme endokrinolojisini olumsuz etkilemektedir. Antiepileptik ilaçlar arasında lamotrigin ürogenital ve cinsel işlevler açısından en nötr profil sergilerken, karbamazepin gibi klasik enzim indükleyiciler serbest testosteron düzeylerini düşürerek erektil disfonksiyona yol açmakta; karbamazepinin keto-türevi olan okskarbazepin ise bu yan etkileri belirgin ölçüde azaltmaktadır. Benzodiazepinler ise GABA-A reseptör aktivasyonu aracılığıyla santral uyarılma eşiğini yükseltmekte, spinal refleksleri baskılamakta ve pelvik taban ile sfinkter kaslarında yarattığı gevşeme sonucu hem cinsel işlev bozukluklarına hem de üriner inkontinansa neden olmaktadır. Bu yan etkilerin Arizona Cinsel Yaşantılar Ölçeği, Kadın Cinsel İşlev İndeksi ve üriner distress envanterleri gibi valide edilmiş araçlarla proaktif izlemi, tedavi uyumunu sürdürmek ve nüksleri önlemek adına klinik pratikte kritik önem taşımaktadır.
Referanslar
Nierenberg, A. A., Agustini, B., Köhler-Forsberg, O., Cusin, C., Katz, D., Sylvia, L. G., Peters, A., & Berk, M. (2023). Diagnosis and Treatment of Bipolar Disorder: A Review. JAMA, 330(14), 1370–1380. https://doi.org/10.1001/JAMA.2023.18588
Chen, B., Choi, H., Hirsch, L. J., Katz, A., Legge, A., Buchsbaum, R., & Detyniecki, K. (2017). Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy and Behavior, 76, 24–31. https://doi.org/10.1016/j.yebeh.2017.08.039
Ferensztajn-Rochowiak, E., & Rybakowski, J. K. (2023). Long-Term Lithium Therapy: Side Effects and Interactions. Pharmaceuticals (Basel, Switzerland), 16(1). https://doi.org/10.3390/PH16010074
Kaufman, K. R., Coluccio, M., Sivaraaman, K., & Campeas, M. (2017). Lamotrigine-induced sexual dysfunction and non-adherence: caseanalysis with literature review. BJPsych Open, 3(5), 249–253. https://doi.org/10.1192/BJPO.BP.117.005538
Özek, S. Ü., Ak, H. C., & Üçler, S. (2020). Sexual dysfunction related with carbamazepine treatment: how much do we ask? Dusunen Adam - The Journal of Psychiatry and Neurological Sciences, 33(3), 328–330. https://doi.org/10.14744/DAJPNS.2020.00099
Bella, A. J., & Shamloul, R. (2013). Psychotropics and sexual dysfunction. Central European Journal of Urology, 66(4), 466. https://doi.org/10.5173/CEJU.2013.04.ART22
Nelson, C. J., Clayton, A. H., Lew-Starowicz, M., Balon, R., Eltantawy, W., Glina, F., & Kirana, P. S. (2026). Psychiatric disorders, psychopharmacology and sexual dysfunction from the fifth international consultation on sexual medicine (ICSM 2024). Sexual Medicine Reviews, 14(2), 17. https://doi.org/10.1093/SXMREV/QEAG017
Grover, S., Ghosh, A., Sarkar, S., Chakrabarti, S., & Avasthi, A. (2014). Sexual dysfunction in clinically stable patients with bipolar disorder receiving lithium. Journal of Clinical Psychopharmacology, 34(4), 475–482. https://doi.org/10.1097/JCP.0000000000000131
McGahuey, C. A., Gelenberg, A. J., Laukes, C. A., Moreno, F. A., Delgado, P. L., McKnight, K. M., & Manber, R. (2000). The arizona sexual experience scale (Asex): Reliability and validity. Journal of Sex and Marital Therapy, 26(1), 25–38. https://doi.org/10.1080/009262300278623
Theobald, J. L., & Aks, S. E. (2024). Lithium. Rosen’s Emergency Medicine: Concepts and Clinical Practice: 2-Volume Set, 1948-1950.e1. https://doi.org/10.1016/B978-0-323-75789-8.00149-3
Finch, C. K., WA Brooks, T., Yam, P., & Kelley, K. W. (2005). Management and treatment of lithium-induced nephrogenic diabetes insipidus. Therapy, 2(4), 669–675. https://doi.org/10.2217/14750708.2.4.669
Bedford, J. J., Weggery, S., Ellis, G., McDonald, F. J., Joyce, P. R., Leader, J. P., & Walker, R. J. (2008). Lithium-induced Nephrogenic Diabetes Insipidus: Renal Effects of Amiloride. Clinical Journal of the American Society of Nephrology : CJASN, 3(5), 1324. https://doi.org/10.2215/CJN.01640408
Cardona R, D. (2018). Use of amiloride in lithium-induced nephrogenic diabetes insipidus. Journal of Analytical & Pharmaceutical Research, Volume 7(Issue 3). https://doi.org/10.15406/JAPLR.2018.07.00242
Jinnouchi, T., Yoshimoto, M., Ogino, K., Oji, T., & Hayashi, M. (2024). Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature. Internal Medicine, 63(10), 1399–1404. https://doi.org/10.2169/INTERNALMEDICINE.2437-23
Kortenoeven, M. L. A., Li, Y., Shaw, S., Gaeggeler, H. P., Rossier, B. C., Wetzels, J. F. M., & Deen, P. M. T. (2009). Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney International, 76(1), 44–53. https://doi.org/10.1038/ki.2009.91
Baird-Gunning, J., Lea-Henry, T., Hoegberg, L. C. G., Gosselin, S., & Roberts, D. M. (2017). Lithium Poisoning. Journal of Intensive Care Medicine, 32(4), 249–263. https://doi.org/10.1177/0885066616651582
Sheibani, M., Ghasemi, M., & Dehpour, A. R. (2022). Lithium and Erectile Dysfunction: An Overview. Cells 2022, Vol. 11, Page 171, 11(1), 171. https://doi.org/10.3390/CELLS11010171
Nolen, W. A., Licht, R. W., Young, A. H., Malhi, G. S., Tohen, M., Vieta, E., Kupka, R. W., Zarate, C., Nielsen, R. E., Baldessarini, R. J., & Severus, E. (2019). What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disorders, 21(5), 394. https://doi.org/10.1111/BDI.12805
Holmskov, M., Christensen, J., Larsen, M. F., Christiansen, A.-E., & Nielsen, R. E. (2026). Polycystic ovary syndrome in women with bipolar affective disorder or epilepsy exposed to valproic acid: a nationwide 16-year cohort study. International Journal of Bipolar Disorders, 14, 6. https://doi.org/10.1186/S40345-026-00411-3
Cansu, A., Gurgen, S. G., Demirhan, Y. N., Ozkan Kart, P., Yildirim, M., Alver, A., Yeni̇lmez, E., & Sönmez, F. M. (2022). Effects of treatment with clinically relevant valproate, carbamazepine, oxcarbazepine, topiramate, lamotrigine and levetiracetam on ovarian folliculogenesis in young rats. Epilepsy Research, 184, 106966. https://doi.org/10.1016/J.EPLEPSYRES.2022.106966
Nelson-DeGrave, V. L., Wickenheisser, J. K., Cockrell, J. E., Wood, J. R., Legro, R. S., Strauss, J. F., & McAllister, J. M. (2004). Valproate Potentiates Androgen Biosynthesis in Human Ovarian Theca Cells. Endocrinology, 145(2), 799–808. https://doi.org/10.1210/EN.2003-0940
Li, S., Zhang, L., Wei, N., Tai, Z., Yu, C., & Xu, Z. (2021). Research Progress on the Effect of Epilepsy and Antiseizure Medications on PCOS Through HPO Axis. Frontiers in Endocrinology, 12, 787854. https://doi.org/10.3389/FENDO.2021.787854/FULL
Zhang, H., Di, M., Wang, Y., Ma, Y., Gou, Y., & Zhou, Z. (2025). Drug-induced polycystic ovary syndrome: a real-world pharmacovigilance study based on the FAERS database. Frontiers in Endocrinology, 16, 1671511. https://doi.org/10.3389/FENDO.2025.1671511/TEXT
Millichap, J. G. (1993). Valproate-Induced Reproductive Disorders. Pediatric Neurology Briefs, 7(12), 90. https://doi.org/10.15844/PEDNEURBRIEFS-7-12-2
Ge, J., Cao, S. S., Cao, X. Y., Tang, M., Mu, F., Qiao, Y., Guan, Y., & Wang, J. W. (2022). Lamotrigine induced priapism in children: case analysis and literature review. Journal of International Medical Research, 50(11). https://doi.org/10.1177/03000605221133988;WGROUP:STRING:PUBLICATION
Akkus, M. (2025). A Case of Dose-Dependent Lamotrigine-Induced Priapism in a Patient with Bipolar Disorder. Noro Psikiyatri Arsivi, 63. https://doi.org/10.29399/NPA.28970
Navarrete-Anaya, V., Delgado-Enciso, I., Hernández-Fuentes, G. A., Diaz-Martinez, J., Delgado-Enciso, O. G., Sánchez-Arizmendi, A., Figueroa-Gutiérrez, A., Aguilar-Cota, J., Venegas-Ramírez, J., Calvo-Soto, P., Carrazco-Peña, K. B., Fuentes-Murguia, M., Ríos-Silva, M., & Guzmán-Esquivel, J. (2025). Insomnia and Benzodiazepine Use as Risk Factors for Erectile Dysfunction: Clinical Evidence and In Silico Analysis of Physicochemical Properties. Journal of Clinical Medicine, 14(19), 6951. https://doi.org/10.3390/JCM14196951
Hosseinzadeh Zoroufchi, B., Doustmohammadi, H., Mokhtari, T., & Abdollahpour, A. (2021). Benzodiazepines related sexual dysfunctions: A critical review on pharmacology and mechanism of action. Revista Internacional de Andrología, 19(1), 62–68. https://doi.org/10.1016/J.ANDROL.2019.08.003
Rogowski, A., Krowicka-Wasyl, M., Dybowski, B., Sienkiewicz-Jarosz, H., Wichniak, A., Samochowiec, J., Wojnar, M., Issat, T., Syrylo, T., Jankiewicz, K., & Bieńkowski, P. (2024). Benzodiazepines use and dependence in female patients with overactive bladder symptoms – prevalence and clinical correlations. Central European Journal of Urology, 77(4), 641. https://doi.org/10.5173/CEJU.2024.0210
Hafiz Ibrahim, A., Rosli Mohd Rosli, R., Noor Norhayati, M., Bahari Ismail, S., Rawatan Keluarga, K., & Pakar, H. (2026). Double Incontinence as Adverse Effect During Brief Usage of Clonazepam. Borneo Journal of Medical Sciences (BJMS), 1(20), 63–68. https://doi.org/10.51200/BJMS.V1I20.5515
Siebenthal, M. von, Schneider, M. P., Zheng, S., Wuethrich, P. Y., Burkhard, F. C., & Monastyrskaya, K. (2021). Effects of opioids and benzodiazepines on bladder function of awake restrained mice. American Journal of Clinical and Experimental Urology, 9(6), 456. https://pmc.ncbi.nlm.nih.gov/articles/PMC8727790/
Grover, S., & Shouan, A. (2020). Assessment Scales for Sexual Disorders—A Review. Journal of Psychosexual Health, 2(2), 121–138. https://doi.org/10.1177/2631831820919581